Phase I results for Imutex’s mosquito vaccine candidate published in leading peer-reviewed journal
Smarttech247 Group (AIM:S247) Admission to AIM and First Day of Dealings
Smarttech247, a multi-award-winning provider of AI enhanced cybersecurity services providing automated managed detection and response for a portfolio of international clients, announces that its Ordinary Shares will today be admitted
Deepverge PLC (AIM:DVRG) Accelerated Restructuring
DeepVerge (AIM: DVRG) announces an organisational restructure of its environmental and life science divisions to meet the growth in demand and maximise the opportunities that lie ahead.
4d Pharma PLC (AIM:DDDD) Blautix Phase II Clinical Trial Results Published
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics
hVIVO PLC (AIM:HVO) £13.6m RSV human challenge study contract with biopharma client
Study cohort sizes increase as clients recognise the benefits of human challenge
Deepverge PLC (AIM:DVRG) Board and Management changes
DeepVerge (AIM: DVRG), announces that further to the announcements of 25 October 2022 and 3 November 2022, Gerard Brandon, Executive Director with responsibility for the Modern Water Division, has resigned
Deepverge PLC (AIM:DVRG) Board Changes
DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus
Open Orphan PLC (AIM:ORPH) Change of name to hVIVO plc effective
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that
Deepverge PLC (AIM:DVRG) Update – Proposed Financing,Proposed Board Changes
DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus
Open Orphan PLC (AIM:ORPH) CFO appointment & change of Board roles
Open Orphan plc (Ticker: ORPH), (to be renamed hVIVO plc (Ticker: HVO) effective 26 October 2022), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious
4d Pharma PLC (AIM:DDDD) MRx0518 poster presentations at SITC 2022
4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)